SCHEMBL7543436

SCHEMBL7543436

CCN1CCN(c2ccc3c(c2)ncn3-c2ccnc(NC(C)C3CN(C(=O)Nc4cccc5ccccc45)CCN3C(=O)OCc3ccccc3)n2)C1=O

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876438 0.89 LCK (1.00) LCK
SCHEMBL7873232 0.89 LCK (1.00) LCK
SCHEMBL7543244 0.89 LCK (1.00) LCK
SCHEMBL7569729 0.89 LCK (0.79) LCK
SCHEMBL7544896 0.89 LCK (0.79) LCK
SCHEMBL7569722 0.89 LCK (0.79) LCK
SCHEMBL7867944 0.89 LCK (0.79) LCK
SCHEMBL7546015 0.88 LCK (0.61) LCK
SCHEMBL7873009 0.87 LCK (0.78) LCK
SCHEMBL7593709 0.87 LCK (0.78) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 US disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed